53 However, in a 96-week phase 3 trial (n=194) of once-weekly exenatide 2 mg in people with moderately severe Parkinsons disease (without diabetes), there was no significant improvement in Parkinsons disease severity compared with placebo
Some researchers use both, theorizing that BPC-157's angiogenic effects and TB-500's cell migration properties provide complementary benefits
Its breadth of mechanisms, excellent oral viability in the arginate form, and compatibility with other healing peptides make it the most versatile option in the category
It has been explored in the management of surgical wounds, burns, and scar remodeling due to its regenerative signaling properties
Key Takeaways CJC-1295 plus Ipamorelin is not FDA approved: There is no approved CJC-1295/Ipamorelin brand, finished drug, or human therapeutic indication
Anti-Inflammatory The anti-inflammatory effects of BPC-157 are well-documented and have been observed in multiple types of tissue, such as the brain, liver, lungs, and GI tract [11, 32]